ESR2 and breast cancer: Knock down of ERβ in MCF 10A or MCF7 cells was shown to cause a significant growth increase of both cell types in a ligand-independent manner [38], while expression of exogenous ERβ in the receptor negative breast cancer cell line MDA-MB-231 inhibited proliferation [39].